Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ginkgo Bioworks Hldgs Inc (NY: DNA )

2.580 +0.200 (+8.40%)
Streaming Delayed Price Updated: 11:48 AM EDT, Jul 5, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 12,686,860
Open 2.400
Bid (Size) 2.570 (181)
Ask (Size) 2.580 (87)
Prev. Close 2.380
Today's Range 2.235 - 2.600
52wk Range 2.090 - 15.86
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Why Ginkgo Bioworks Shares Are Rising After Announcement With Partner Cronos Group
Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading higher by 7.63% to $2.68 after the company, and Cronos Group Inc (NASDAQ: CRON), announced the achievement of the third target productivity... 
Via Benzinga
Cronos Group And Ginkgo Bioworks Achieve Rare Cannabinoid THCV Equity Milestone
Cronos Group Inc. (NASDAQ: CRON) (TSX:CRON) and Ginkgo Bioworks (NYSE: DNA) achieved the third target productivity milestone in their partnership 
Via Benzinga

Performance

YTD
-70.31%
-70.31%
1 Month
-25.65%
-25.65%
3 Month
-37.53%
-37.53%
6 Month
-70.31%
-70.31%
1 Year
-79.95%
-79.95%

More News

Read More
The Daily Biotech Pulse: Veru Seeks Emergency Use Nod For COVID-19 Therapy, Vincerx Cuts Workforce, Moderna Starts Dosing In Flu Vaccine Study
Via Benzinga
Cathie Wood Is Selling Gene Editing Stocks. Here’s Why.
Via InvestorPlace
Cathie Wood Keeps Buying Gingko Bioworks (DNA) Stock
Via InvestorPlace
Losing Money Is in Ginkgo Bioworks Holdings’ DNA
Via InvestorPlace
Why Ginkgo Bioworks Stock Is Falling After Hours
Via Benzinga
Earnings Scheduled For May 16, 2022
Via Benzinga
74 Biggest Movers From Yesterday
Via Benzinga
ADSK Stock Sinks 8% Following Analyst Downgrade
Via InvestorPlace
Why Is Ginkgo Bioworks (DNA) Stock Up Today?
Via InvestorPlace
Benzinga Bulls And Bears Of The Week: Netflix, Coinbase, Apple, Rivian And A Biotech Scooped Up By Cathie Wood
Via Benzinga
Tesla Bull Cathie Wood Scoops Up $11.5M In Bill Gates-Backed Biotech's Stock
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2022
Via Benzinga
BofA Downgrades Ginkgo Bioworks, Cuts Price Target In Half
Via Benzinga
Mid-Afternoon Market Update: Crude Oil Down Over 1%; Jumia Technologies Shares Spike Higher
Via Benzinga
Looking Into Ginkgo Bioworks Holdings's Recent Short Interest
Via Benzinga
7 Growth Stocks to Buy on the Dip
Via InvestorPlace
Cathie Wood Keeps Buying Gingko Bioworks (DNA) Stock. Here’s Why.
Via InvestorPlace
7 Biggest Loser Stocks That Could Become Surprising Buys
Via InvestorPlace
28 Biggest Movers From Yesterday
Via Benzinga
NYSE:DNA Long Term Investor Alert: Investigation of Potential Wrongdoing at Ginkgo Bioworks Holdings, Inc.
Via SBWire
Elanco, Ginkgo Bioworks Launch BiomEdit, Microbiome-Focused Animal Health Firm
Via Benzinga
Baillie Gifford Just Bought Ginkgo Bioworks (DNA) Stock. Here’s Why.
Via InvestorPlace
Twist Bioscience and Ginkgo Bioworks Sign New Collaboration
From Twist Bioscience Corporation
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.